Few & Far Between: Conversations from the Front Lines of Drug Development

Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.

Latest Episodes

13

October 27, 2021 00:50:12
Episode Cover

Episode 13: Kelly Franchetti RN, SVP, Global Head Patient Insights and Strategy at YPrime

How has patient advocacy grown to become the driver of rare disease drug development? In today's episode of Biorasi's Few & Far Between podcast,...

Listen

12

October 13, 2021 00:46:48
Episode Cover

Episode 12: Effie Parks and Spela Mirosevic

Social media platforms and podcasts are spotlighting the untold stories of rare disease patients and their families. Find out more in today's Few &...

Listen

11

September 28, 2021 00:34:38
Episode Cover

Episode 11: Rebecca Stewart and Nicola Miller from Rare Revolution Magazine

How important is transparency to the rare disease community? Today's full episode of Few & Far Between features Biorasi's Lindsey Rios, with guests Rebecca...

Listen

10

September 15, 2021 00:44:02
Episode Cover

Episode 10: Sharon Terry, CEO Genetic Alliance

Why is the sharing of data so crucial to #raredisease research? Tune in for today's full episode of Few & Far Between. Episode 10...

Listen

9

September 01, 2021 00:47:27
Episode Cover

Episode 9: Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP

Tune in for today's full episode of Few & Far Between. Episode 9 features Biorasi's Becky Knockemus, Zogenix, Inc.'s Dawn Blessing, and J. Michael...

Listen

8

August 18, 2021 00:41:04
Episode Cover

Episode 8: David Rose, Rare Disease Speaker and Advocate

On today's podcast, speaker and rare disease advocate David Rose talks with Biorasi's Dr. Raul Silveira about occipital horn syndrome and supporting rare disease...

Listen